May 30, 2017
Related News
Other posts that you should not miss.
Belfast based respiratory diagnostics company, ProAxsis is investing over £200,000 in R&D to enhance its novel ProteaseTag® …
July 27, 2020
ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman of the company’s Board …
October 25, 2019
ProAxsis will be presenting further data on its ProteaseTag® technology, at the North American Cystic Fibrosis Conference, …
October 30, 2017
